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Supplementary Figure 4:
The effect of cisplatin (CSP), cyclophosphamide (CYCLO) and chlorambucil (CLB) when used in combination with quercetin (QUE), apigenin (AP), emodin (EMO), rhein, (RH) or cis-stilbene (CIS) on apoptosis morphological changes; in two lymphoid (Jurkat and CCRF-CEM) and two myeloid (THP-1 and KG-1a) leukaemia cell lines. This was evaluated by double staining with Hoechst 33342/PI using fluorescence microscopy. Cells were treated with CSP, CYCLO or CLB and polyphenols alone and in combination for 24 h using their lowest-significant doses (LSD). Data was normalised to the vehicle control, which was assigned 0% apoptosis. The data was expressed as medians with ranges (N = 4). Effects of combination treatments were statistically classified as synergistic (*) causing an increase in apoptosis or antagonistic (#) causing a decrease in apoptosis; when compared to vehicle control, drugs alone and expected values of combination treatments. Statistical significant was set at P ≤ 0.05.
